We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

BAC and Octapharma Extend Recombinant Factor IX Collaboration for Clinical and Commercial Scale Production, and Initiate a Further Blood Disorder Programme

News   Nov 02, 2009

 
BAC and Octapharma Extend Recombinant Factor IX Collaboration for Clinical and Commercial Scale Production, and Initiate a Further Blood Disorder Programme
 
 
 

RELATED ARTICLES

Unearthing the Proteome of the Sweet Potato

News

The sweet, starchy orange sweet potatoes are tasty and nutritious ingredients for fries, casseroles and pies. Although humans have been cultivating sweet potatoes for thousands of years, scientists still don't know much about the protein makeup of these tubers, until now.

READ MORE

Sickle Cell Drug IMR-687 Shows Promise in Clinical Trial

News

An investigational drug for the treatment of sickle cell disease shows early promise in Phase 2a clinical trial. The orally administered drug, given to adult patients with sickle cell disease, is demonstrating tolerability and the ability to impact both red and white blood cell biomarkers of the disease.

READ MORE

A New Role for Cohesin Protein in Tumors and Rare Diseases?

News

Cohesin mutations have been identified in some types of cancer and in rare diseases referred to as cohesinopathies. Now, scientsits describe new functions of cohesin in mouse embryonic stem cells that might help understand and address the causes of these disorders.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE